Page 51 - 2019食藥署年報(英文版)
P. 51

4FDUJPO    $SFBUF B /FX *OUFSOBUJPOBM 1BUUFSO PG 1IBSNBDFVUJDBMTFDUJPO
                     4


                     0SJHJO PG 1PMJDZJHJO PG 1PMJDZ
                     0S
                         TFDA has worked hard to promote international cooperation in pharmaceutical products
                     over the years. We actively participated in international organizations and strive to hold
                     international conference activities to strengthen Taiwan’s international participation and
                     LQÀXHQFH  DQG EXLOG DQ LQWHUQDWLRQDO UHJXODWRU\ HQYLURQPHQW RI SKDUPDFHXWLFDO SURGXFWV  7KH
                     direction of implementations in 2018 are as follows:


                         5BLF UIF JOJUJBUJWF UP CFDPNF B SFHVMBUPSZ NFNCFS PG *$)

                         The International Council for Harmonisation of Technical Requirements for
                     Pharmaceuticals for Human Use (ICH) is an international organization cofounded by the
                     pharmaceutical administration and the pharmaceutical industry of the European Union, Japan
                     and the United States in 1990. The Council aims to develop drug guidelines that can be accepted
                     by various countries and recognized as global technical standards through international
                     discussions in various regions. We hoped to join the ICH and participate in the stipulation of

                     international standards, avoid the technical regulation obstacles, and create opportunity of
                     cooperation amongst members, so that our domestic drug management regulations could meet
                     the international standards.

                         -POH UFSN QBSUJDJQBUJPO JO UIF "TJB 1BDJGJD &DPOPNJD $PPQFSBUJPO

                         "1&$  UP QSPNPUF SFHVMBUPSZ DPOWFSHFODF

                         To promote international information exchange and cooperation in drug management
                     and regulatory harmonization, TFDA has been long-term participating in the Regulatory
                     +DUPRQL]DWLRQ 6WHHULQJ &RPPLWWHH  5+6&  RI WKH $VLD 3DFL¿F (FRQRPLF &RRSHUDWLRQ  $3(&
                     Life Science Innovation Forum. TFDA co-champions the "Good Registration Management

                     (GRM)" priority work area with Ministry of Health, Labour and Welfare (MHLW) and the
                     Pharmaceuticals and Medical Devices Agency (PMDA) of Japan. In addition, TFDA was
                     endorsed as an APEC Regulatory Science Training Center of Excellence in the area of GRM and
                     has been providing training each year in Taiwan. Through cooperation between the competent
                     authorities and the pharmaceutical industry, promoting GRM has been enhancing the mutual
                     trust between the competent authorities and the pharmaceutical industry and the regulatory
                     convergence amongst APEC member economies by 2020.









                                                                                                           49
   46   47   48   49   50   51   52   53   54   55   56